← Back to Search

Behavioural Intervention

Integrated Behavioral Health for Adolescent Opioid Use Disorder

N/A

Waitlist Available

Led By Leslie A Hulvershorn, MD

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients included in administrative data must be a patient at one of the participating pediatric primary care teams and be 12-18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from clinical trial launch, data will be collected twice a year, for a total of four years.

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to improve the way pediatric primary care providers help adolescents with substance use disorder (SUD) and opioid use disorder (OUD). The project will offer stigma-reduction interventions and SUD

Who is the study for?

This trial is for adolescents at risk of or struggling with substance use disorders (SUD) and opioid use disorder (OUD). It's aimed at improving care within pediatric primary care settings. Participants are likely to be those who regularly visit their pediatricians for annual wellness checks.

What is being tested?

The study tests an Integrated Behavioral Health System enhanced with SUD resources in pediatric primary care. The goal is to see if this system helps doctors provide better SUD/OUD treatment compared to standard practices, potentially leading to improved health outcomes.

What are the potential side effects?

Since the intervention involves healthcare system changes rather than medication, traditional side effects aren't expected. However, there may be indirect impacts on patients' experiences such as discomfort during discussions about substance use or stigma-related challenges.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 12 and 18 years old and see a doctor at a participating pediatric care team.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from clinical trial launch, data will be collected twice a year, for a total of four years.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from clinical trial launch, data will be collected twice a year, for a total of four years.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from clinical trial launch, data will be collected twice a year, for a total of four years. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of Intervention, Intervention Appropriateness Measure, Feasibility of Intervention Measure

Attitudes of Medication Opioid Use Disorder (MOUD) Treatment

Attribution Questionnaire - SUD

+13 more

Secondary study objectives

Fatal overdose

Nonfatal overdose

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Integrated Behavioral Health with SUD ResourcesExperimental Treatment1 Intervention

Participating clinics receive a system-level intervention, an Integrated Behavioral Health System with SUD Resources, designed to improve youth connection to substance use treatment.

Group II: Primary Care Practice As UsualActive Control1 Intervention

Data are collected regarding standard primary care practice and outcomes before implementation of SUD resources within the Integrated Behavioral Health System.

0 / 1Eligibility criteria met